The Methodology

A Structured 12-Week Integration Programme

GLP-1 Integration is a preventative co-intervention delivered alongside treatment, focused on long-term stability rather than short-term weight loss. It is designed for the early transition window when support is most effective.

This makes it a time-sensitive personalised relapse-risk reducing intervention, not a generic coaching programme.

Explore Methodology

Method Positioning

Prevention matters as much as intervention.

In medical treatment pathways, prevention matters as much as intervention. GLP-1 Integration is designed to reduce relapse risk during the specific phase when change is still stabilising, rather than acting as a broad or generic coaching offer.

Programme Phases

A Structured 12-Week Integration Programme

01

Mindset Reset

Weeks 1-2

Rapid Transformational Therapy increases awareness and understanding of why you worry about weight regain, helping reprogramme your mindset for steadier maintenance.

Phase 01 - Mindset Reset

02

Identity & Safety Consolidation

Weeks 3-6

Imposter Syndrome informed coaching stabilises confidence in your new body, reduces feelings of imposterism, and reduces the risk of self-sabotage during change.

Phase 02 - Identity & Safety Consolidation

03

Behavioural Integration

Weeks 7-12

Normalisation Process Theory informed behavioural coaching embeds personalised lifestyle experimentation so sustainable habits can take hold one small change at a time.

Phase 03 - Behavioural Integration

What GLP-1 Integration Is

A 12-week behavioural adjunct programme delivered alongside GLP-1 treatment, focused on long-term stability rather than short-term weight loss. It addresses mindset and habits that commonly affect long-term outcomes, including anxiety, shame, fear of regain, and disengagement after early success.

Scope of Practice

Behavioural coaching and therapeutic support only. We do not provide healthcare services, dietary planning, or professional medication advice.

Wider Care Pathway

It functions as a structured bridge between active pharmacological treatment and independent long-term maintenance within the wider GLP-1 care pathway.